Asset Allocation

As of March 31, 2026.
Type % Net
Cash 27.02%
Stock 51.79%
Bond 26.89%
Convertible 0.00%
Preferred 0.38%
Other -6.08%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 82.88%    % Emerging Markets: 1.91%    % Unidentified Markets: 15.21%

Americas 86.20%
85.77%
Canada 3.78%
United States 81.99%
0.43%
Brazil 0.05%
Chile 0.38%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe -1.33%
United Kingdom -1.66%
0.32%
France 0.00%
Germany 0.36%
Ireland 0.75%
Italy 0.02%
Netherlands -0.21%
Spain -0.57%
Switzerland -0.03%
0.00%
0.00%
United Arab Emirates 0.00%
Greater Asia -0.08%
Japan 0.00%
0.00%
Australia 0.00%
-0.08%
Singapore -0.01%
Taiwan -0.06%
0.00%
Unidentified Region 15.21%

Bond Credit Quality Exposure

AAA 0.00%
AA 30.83%
A 0.00%
BBB 2.00%
BB 6.18%
B 12.03%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 48.96%
Short Term 0.00%
As of March 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
9.68%
Materials
2.32%
Consumer Discretionary
-0.18%
Financials
5.96%
Real Estate
1.57%
Sensitive
23.17%
Communication Services
7.99%
Energy
0.24%
Industrials
10.85%
Information Technology
4.09%
Defensive
23.05%
Consumer Staples
1.20%
Health Care
22.07%
Utilities
-0.23%
Not Classified
0.81%
Non Classified Equity
0.81%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 67.90%
Corporate 21.19%
Securitized 0.00%
Municipal 0.00%
Other 10.91%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
56.07%
Less than 1 Year
56.07%
Intermediate
43.93%
1 to 3 Years
18.72%
3 to 5 Years
15.31%
5 to 10 Years
9.90%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of March 31, 2026
View Bond Maturity Exposure
Start Trial